Literature DB >> 16300915

The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats.

Xiao Yanyu1, Song Yunmei, Chen Zhipeng, Ping Qineng.   

Abstract

The aim of the present study was to find a way of prepare silybin-phospholipid complex to make oral bioavailability of silybin increase and to study its physicochemical properties and to compare the pharmacokinetic characteristics and bioavailability after oral administration of silybin-phospholipid complex and silybin-N-methylglucamine in rats. Using ethanol as a reaction medium, silybin and phospholipids were resolved into the medium, after the organic solvent was removed under vacuum condition, silybin-phospholipid complex was formed. The new complex's physicochemical properties including scanning electron microscopy (SEM), transmission electron microscopy (TEM), differential scanning calorimetry (DSC), solubility, dissolution, etc., were tested. The concentrations of silybin after oral administration of silybin-phospholipid complex and silybin-N-methylglucamine at different time in rats were determined by RP-HPLC. The pharmacokinetic parameters were computed by software program 3p97. Our data showed that silybin and phospholipids in the silybin-phospholipid complex were combined by non-covalent-bond, not forming a new compound and the solubility of silybin-phospholipid complex in water and in n-octanol was effectively enhanced. We found that mean plasma concentration-time curve of silybin after oral administration of silybin-phospholipid complex and silybin-N-methylglucamine in rats was both in accordance with open single-compartment model with first-order absorption. Pharmacokinetic parameters of silybin in rats were Tmax 10 and 5 min; Cmax 126.72 and 104.29 ng ml(-1); AUC(0-infinity) 1020.33 and 235.81 ng ml(-1)h, respectively. The bioavailability of silybin in rats was increased remarkably after oral administration of silybin-phospholipid complex comparing to silybin-N-methylglucamine. This was mainly due to an impressive improvement of the lipophilic property of silybin-phospholipid complex and improvement of the biological effect of silybin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16300915     DOI: 10.1016/j.ijpharm.2005.10.001

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  41 in total

Review 1.  Silybin and the liver: from basic research to clinical practice.

Authors:  Carmela Loguercio; Davide Festi
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

Review 2.  Bioavailability enhancers of herbal origin: an overview.

Authors:  Kritika Kesarwani; Rajiv Gupta; Alok Mukerjee
Journal:  Asian Pac J Trop Biomed       Date:  2013-04

3.  Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phospholipid-mixed micelles.

Authors:  Jiang-nan Yu; Yuan Zhu; Li Wang; Min Peng; Shan-shan Tong; Xia Cao; Hui Qiu; Xi-ming Xu
Journal:  Acta Pharmacol Sin       Date:  2010-06       Impact factor: 6.150

4.  Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo.

Authors:  Chang Chu; Shan-shan Tong; Ying Xu; Li Wang; Min Fu; Yan-ru Ge; Jiang-nan Yu; Xi-ming Xu
Journal:  Acta Pharmacol Sin       Date:  2011-06-13       Impact factor: 6.150

5.  Mixed micelles loaded with silybin-polyene phosphatidylcholine complex improve drug solubility.

Authors:  Rui-ling Duan; Xun Sun; Jie Liu; Tao Gong; Zhi-rong Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-12-20       Impact factor: 6.150

6.  Promoted Antitumor Activity of Myricetin against Lung Carcinoma Via Nanoencapsulated Phospholipid Complex in Respirable Microparticles.

Authors:  Noha Nafee; Dina M Gaber; Ahmed O Elzoghby; Maged W Helmy; Osama Y Abdallah
Journal:  Pharm Res       Date:  2020-04-14       Impact factor: 4.200

7.  A novel matrix dispersion based on phospholipid complex for improving oral bioavailability of baicalein: preparation, in vitro and in vivo evaluations.

Authors:  Yang Zhou; Wujun Dong; Jun Ye; Huazhen Hao; Junzhuo Zhou; Renyun Wang; Yuling Liu
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

8.  Preparation, characterization and in vivo evaluation of bergenin-phospholipid complex.

Authors:  Xuan Qin; Yang Yang; Ting-ting Fan; Tao Gong; Xiao-ning Zhang; Yuan Huang
Journal:  Acta Pharmacol Sin       Date:  2009-12-07       Impact factor: 6.150

9.  Combination of Phospholipid Complex and Matrix Dispersion.

Authors:  Ravi Kumar Chakravarti; Shamandeep Kaur; Sanjaya K Samal; Mahesh C Kashyap; Abhay T Sangamwar
Journal:  AAPS PharmSciTech       Date:  2021-06-22       Impact factor: 3.246

10.  Process optimization, characterization and pharmacokinetic evaluation in rats of ursodeoxycholic acid-phospholipid complex.

Authors:  Peng-Fei Yue; Wen-Jin Zhang; Hai-Long Yuan; Ming Yang; Wei-Feng Zhu; Pei-Lie Cai; Xiao-He Xiao
Journal:  AAPS PharmSciTech       Date:  2008-02-07       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.